CytomX Therapeutics (CTMX) Net Income Growth (1y) (2015 - 2026)
CytomX Therapeutics (CTMX) Net Income Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-43.69% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-73.01% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-290.15% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
59.59% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CytomX Therapeutics |
520.30 Mn |
173.59 Mn |
- |
-177.57% |
| Date | Value |
|---|
| Mar 31, 2026 |
-177.57% |
| Dec 31, 2025 |
-240.44% |
| Sep 30, 2025 |
-348.06% |
| Jun 30, 2025 |
97.64% |
| Mar 31, 2025 |
70.58% |
| Dec 31, 2024 |
2,155.20% |
| Sep 30, 2024 |
91.71% |
| Jun 30, 2024 |
-501.10% |
| Mar 31, 2024 |
516.52% |
| Dec 31, 2023 |
109.54% |
| Sep 30, 2023 |
110.29% |
| Jun 30, 2023 |
96.31% |
| Mar 31, 2023 |
89.65% |
| Dec 31, 2022 |
74.80% |
| Sep 30, 2022 |
6.19% |
| Jun 30, 2022 |
-10.32% |
| Mar 31, 2022 |
-37.09% |
| Dec 31, 2021 |
-45.12% |
| Sep 30, 2021 |
-23.77% |
| Jun 30, 2021 |
-5.68% |
